Flavonoids Exhibit Potential Antagonistic Activity Against Platelet-Activating Factor (PAF) Receptor

Document Type

Article

Publication Date

1-1-2022

Abstract

The platelet-activating factor receptor (PAFR) has been a therapeutic target for platelet-activating factor (PAF)-mediated diseases. The pathophysiological condition is triggered by the interaction of PAF agonist. The discovery of PAF antagonists from natural flavonoids could be promising candidates for treating PAF-mediated diseases. Flavonoids that exist in most edible plants possess good health benefits to the human body. The study aimed to investigate the ability of three flavonoids (apigenin, galangin and fisetin) for molecular docking and dynamic simulations into PAFR protein. The PAFR-flavonoid complex binding affinities and interactions were assessed through molecular docking and dynamic simulations. Results found that all flavonoids significantly have a good binding affinity, ranging from-9.1 to-8.9 kcalmol-1. The stability of these flavonoids was also achieved in a 30 ns simulation. Four critical residues were detected in all PAFR-flavonoids complexes (Phe97, Phe98, Thr101 and Leu279) from the analysis of MMGBSA binding free energy. Interactions of van der Waals and electrostatic were seen by individual key residues of PAFR for the free energy contribution of ligands binding. All flavonoids showed promising anti-PAF candidate to be developed in the future. © 2022 Nordin et al.

Keywords

Apigenin, Fisetin, Galangin, Thrombocyte activating factor receptor, Antagonistic effect, Article, Binding affinity, Binding site, Edible plant, Finite element analysis, Hydrogen bond, Molecular docking, Molecular dynamics, Nonhuman, Protein structure, Simulation, Static electricity

Divisions

pharchemistry

Funders

Universiti Sains Islam Malaysia [Grant No ;PPP/FPSK/0118/051000/14918]

Publication Title

Tropical Journal of Natural Product Research

Volume

6

Issue

10

Publisher

Faculty of Pharmacy, University of Benin

This document is currently not available here.

Share

COinS